Y-Intercept (HK)’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$578K	Buy	44,432 +21,355	+93%	+$278K	0.01%	1157
2025 Q1	$244K	Buy	+23,077	New	+$244K	0.02%	976
2024 Q3	–	Sell	-17,991	Closed	-$438K	–	1288
2024 Q2	$438K	Buy	+17,991	New	+$438K	0.02%	875